At a glance
ClinicalIndex Comparison RecordN/ACompleted· 81 enrolled
Drug / intervention
Paclitaxel Releasing Balloondevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Paclitaxel Releasing Balloon in Patients Presenting With In-Stent Restenosis A Prospective, Multi-centre, Non-randomized Clinical Trial With Follow-up Investigations at 1, 6 and 12 Months
In Brief
A clinical study evaluating Paclitaxel Releasing Balloon for In-stent Coronary Artery Restenosis. Completed, enrolled 81 participants across 1 site.
Detailed Summary
The primary objective of this study is to evaluate the safety and efficacy of the paclitaxel releasing balloon in patients with in-stent restenosis in a coronary artery.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsIn-stent Coronary Artery Restenosis
CountriesGermany
Collaborators--
Timeline
N/ACompletedFinished
20102011201220132014201520162017201820192020202120222023202420252026
Enrollment StartAug 2009
First PostedAug 2009
Primary CompletionDec 2010
Study CompletionMay 2011
TodayJul 2026
First PostedAug 18, 2009
Enrollment StartAug 1, 2009
Primary CompletionDec 1, 2010
Study CompletionMay 1, 2011
TodayJul 2, 2026
Enrollment to primary: 1.3 yearsPosted 16.9 years ago
Interventions
Paclitaxel Releasing Balloondevice
Percutaneous coronary intervention with paclitaxel releasing balloon